4 results
The primary objective is to determine the incidence of HFS in first line treatment with S-1 compared to capecitabine in patients with metastatic colorectal cancer. Secondary objectives include a comparison of efficacy.
In this study we aim to evaluate the feasibility of a mobile application guiding IBD patients during biologic treatment.
Cohort 1 (HER2-positive/amplified MBC): MCLA-128 + trastuzumab ± vinorelbine Primary objective:• Evaluate efficacy of MCLA-128 combined with trastuzumab ± vinorelbine in terms of clinical benefit rate (CBR) at 24 weeks based on RECIST 1.1 (per…
In this study we will assess the (cost)effectiveness of a transmural integrated care programme supporting return to daily activities (including work)after knee arthroplasty compared to usual care. We hypothesize our transmural integrated care…